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Abstract

Introduction

Calcium oxalate (CaOx) crystallization in the presence of phosphocitrate (PC) was studied by both in vitro
and in vivo techniques. Crystals of the monohydrate
(COM) and the dihydrate (COD) forms were generated
under controlled conditions in a silica gel matrix. Our
data indicated only COD crystals formed when PC was
present, inferring that the COD to COM transformation
was being impeded. COD crystals were smaller in size
than controls and there was evidence of interpenetral
twinning. An in vivo study using a rat bladder implant
model noted similar findings. Scanning electron microscopy (SEM) revealed that implants recovered from PC
treated rats had primarily COD crystals deposited,
whereas both the surface and inner layers of encrusted
implants from normal rats contained predominantly
COM crystals. Infrared (IR) analysis confirmed the
visual findings indicating quantitatively that there was a
higher proportion of COD present on the implants recovered from the treated rats than in the controls. It is concluded that although total CaOx crystallization cannot be
eliminated by PC, its action could assist in reducing the
harmful nature of such crystallites in the urine.

The influence of both small and macromolecular inhibitors of the nucleation and growth of urinary crystallites has been widely reported together with speculation
of their mechanisms of action (Pak et al., 1975; Tomazic and Nancollas, 1980; Coe et al ., 1991; Nancollas et
al., 1991; Tiselius et al., 1993). Some compounds
naturally display more inhibitory power than others, a
characteristic which appears to relate to a number of
functions including ionic charge, size, stereochemistry
and the compound's relationship to the changing face of
growing crystals (Williams and Sallis, 1982) .
Phosphocitrate (PC) is a compound with no known
toxic side effects and with a strong inhibitory action
again st the crystallization of hydroxyapatite, calcium
oxalate (CaOx) and mixed stone phosphate salts (Tew et
al., 1980; Williams and Sallis, 1982; Brown and Sallis,
1983; Shankar et al., 1984; Sallis et al., 1989; Achilles
et al., 1990). To date, however, very few data have
been accrued on the nature of PC-crystal interface interactions. On the basis of reported morphological changes
to crystals in the presence of other weaker inhibitors
(Martin et al., 1984; Marickar and Koshy , 1987), it
might be predicted that crystal habit should be changed
by PC. Certainly, a reduction in CaOx monohydrate
(COM) particle size as demonstrated by the constant
composition technique is known to occur (Richardson et
al ., 1990), and it has also been found that PC exhibits
a strong surface binding affinity, much more so than is
seen for example with citrate. Such data then have encouraged us to look at crystal habit of both the dihydrate
and monohydrate forms of CaOx, as influenced by PC.
Growing crystals in vitro in the presence of inhibitors in a gel medium is one technique for studying their
changing morphology. LeGeros and Morales (1973) and
Marickar and Koshy (1987) have previously reported
their observations on CaOx, brushite, and mixed stone
crystallization. Techniques such as scanning electron
microscopy (SEM), infrar ed (IR) analysis and X-ray
diffraction, can then be applied to reveal more detailed
structural, morphological and compositional aspects of
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COM preparation above was replaced by MgC12 , giving
a Ca 2 +:Mg 2 + ratio of 3: 1 (LeGeros and Morales,
1973). PC was dissolved in the metasilicate solution
prior to setting, to give final concentrations of either 560
µMor 2.2 mM.

the crystals. Whilst an in vitro gel system is regarded
as generating reliable and useful information and can do
so under well defined growth conditions, confirmation of
the findings needs to be followed up in vivo where the
nature of the environment is much more complex. One
animal model which we and others have used effectively
(Khan et al.; 1984, Khan and Hackett, 1985a; Sallis et
al., 1988) is based upon an original study by Vermeulen
et al. (1950). The model involves the implantation of a
foreign body into the bladder of a rat to act as a nucleus
for crystal growth. Khan et al. (1984) implanted a polymeric disk as the foreign body to provide later advantages in SEM examination of encrusted disks. Their
studies have included morphological, kinetic and growth
patterns of CaOx crystal formation under hyperoxaluric
conditions (Khan et al., 1984; Khan and Hackett, 1985a,
1985b).
In the current studies, we describe the morphological and growth changes to COM and CaOx dihydrate
(COD) crystals brought about by the presence of PC.
Data obtained from an in vitro gel matrix system have
been compared to changes observed when crystals are
grown on polymer implants in the bladder of rats. Analysis by SEM and IR has provided evidence of the nature
and extent of these changes when influenced by PC.

Production of epoxy resin implants
A modification to the method described by Khan et
al. (1984) was used to manufacture hemispherical disks
of epoxy resin. An homogeneous mixture of vinyl cyclohexene dioxide (10 g), nonenylsuccinic anhydride (26
g) and diglycidyl ether of polypropylene glycol (6 g) was
prepared to give an epoxy resin of medium hardness.
This was left for 10-15 minutes with constant stirring,
care being taken to avoid bubbles. Dimethyl aminoethanol (0.4 g) was then added to harden the mixture, and
the final product used within 24 hours.
Lead mould impressions were made using glass
beads pressed firmly between two lead sheets. A 12 µ1
portion of the epoxy resin mixture was pipetted into each
impression in the lead plates, and polymerization was
achieved at 60-70°C over 8 hours. The formed disks
were released from the moulds and polished with fine
sandpaper. They were 4 mm in diameter, with an average mass of 13.5 mg. The finished product proved suitable for insertion without damage to the bladder.

Experimental regime

Materials and Methods

In all in vivo experiments, male Hooded Wistar rats
(240-260 g) were used . The surgical procedure was
similar to that described by Vermeulen et al. (1950) and
as we have previously reported (Sallis et al., 1988). All
surgical instruments were steam sterilized between operations, and the implants presoaked in 70 % isopropanol.
Rats were anaesthetized with halothane-oxygen (1.5 %
halothane, oxygen flow rate: 300 cm3/min), and 70 %
isopropanol and 0.5 % Hibitane (ICI Australia, Ltd.), respectively, were swabbed onto the fur and skin site before making an external suprapubic incision . A small
incision at the proximal end of the exposed bladder enabled the implant to be inserted. The bladder and body
wall incisions were then closed with silk sutures, and the
external wound closed with cotton sutures and swabbed
with Panolog ointment (E.R.Squibb and Sons, Pty . Ltd. ,
Victoria, Australia) . No additional antibiotic treatment
was required as in our experience, and indeed others
(Khan and Hackett, 1985b), urinary tract bacterial infections never developed. Following a 24 hour recovery
period, the rats were placed on an hyperoxaluric diet
(day 1) comprising normal rat chow premixed to contain
1 % added glycolate.
Daily doses (9:30 a.m. and 4:30 p.m.) of PC were
administered from day l by intraperitoneal (ip) administration, at a dose rate of 250 mg PC/kg body weight/
day. Sustained administration at this level does not

PC was prepared by phosphorylation of triethyl or
tribenzyl citric acid using methods previously reported
(Tew et al., 1980; Williams and Sallis, 1980; Pankowski
et al., 1994). Following deprotection of the phosphorylated intermediate through hydrogenation and base hydrolysis, the sodium salt of PC was crystallized from
water. The compound was assayed and characterized by
our earlier reported techniques (Williams and Sallis,
1980).

Preparation of gels containing COM and COD
crystals
Silicate gels were prepared essentially as described
by Marickar and Koshy (1987). Sodium metasilicate
(density = 1.03) was rapidly adjusted to pH 6 with acetic acid (3 M) before pouring into 12 mm diameter U
tubes, each limb being 150 mm high. Once set, COM
crystals were formed by pouring 5 ml sodium oxalate
(NaOx) solution (1 M) in the left limb and 5 ml calcium
chloride (1 M) in the right limb of the U tube . Conditions for concurrent COM and COD nucleation and
growth were established by pouring NaOx (1 M) into the
left limb and an equal quantity of a mixed solution of
CaC12 (1 M) and magnesium acetate (1 M) into the right
limb. Conditions for COD development were established when part of the CaC12 solution used for the
128

Phosphocitrate inhibition of calcium oxalate

C
Figure 1. Characteristic morphologie s of COM and
COD crystals formed in silicate gel in the presence or
absence of PC, under COM growth conditions. (a).
Control. (b) . PC (560 µM). (c) . PC (2 .22 mM).
Bars = 100 µm .

induce changes to urinary parameters (Sallis et al.,
1988). Rats were divided into a control group (13 rats)
and a treated group (12 rats), the controls receiving a
placebo injection of 0 .9 % saline and handled in a like
manner. Termination of the experiment occurred on day
28, when the rats were sacrificed, and the implanted
discs recovered from the bladder. Immediately upon removal, the crystal encrusted implants were placed in a
desiccator and dried with silica gel as the desiccant.
Scanning electron microscopy

Stone samples (as above) were mounted on stubs (13
mm diameter) with double-sided adhesive tape and
coated with high-purity gold before being examined by
SEM , using a Philips SEM 505 analyzer.
Infrared analysis of stone crystalline composition

IR spectra were registered between 4000 cm- 1 and
500 cm- 1 on a Digilab FTS-20E Fourier transform infrared spectrometer (USA). Crystal material was carefully
scraped off implants with a scalpel blade , and 1 mg of
129
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Figure 2. Characteristic morphologies of COD crystals
formed in silicate gel in the presence or absence of PC,
under COD growth conditions. (a) . Control. (b). PC
(2.22 mM). Bars = 100 t,lm,

this material was compressed with KBr to form a pellet
(disk) under vacuum.
Standard COM and COD crystals were prepared by
the method of Grases et al. (1990). COM was prepared
by adding 250 ml each of 7.5 mM NaOx and 7.5 mM
CaC12 solutions simultaneously over 1 hour to 7 liters of
distilled water heated to 70°C. The slurry so formed
was then filtered, and the remaining crystals washed
with water and ethanol, before being vacuum dried for
24 hours at 50°C. Preparation of the COD crystals
involved adding 50 ml of CaC12 (0.25 M) dropwise to a
200 ml solution containing NaH 2PO 4 (43.6 mM),
NazHPO 4 (6.1 mM), NaCl (0.23 M), trisodium
citrate.2H 2 O (3.9 mM), Na 2 SO4 (34.2 mM),
MgSO 4 .7H 2 O (5.9 mM), NH 4Cl (86.7 mM), KCI (0.16
M) and NaOx (1.9 mM). This solution was continuously stirred in an ice bath (4 °C) for 1 hour. The slurry
was then filtered and the crystals washed with water and
absolute ethanol.
KBr pellets of COM and COD standards were analyzed by IR to provide reference spectra for the stone
material obtained in the bladder. The percentage COD
present in a deposit on an implant was calculated from
its IR spectra using the regression equation of Martin et
al. (1984):

••

y

= 302 · 1 x R - 11.9

(1)

where y is the fractional content in percentage of COD
in the sample, and R is the ratio of the absorbances at
910 and 780 cm- 1.
Results

In vitro gel system
Growth of crystals within the gels in less than 48
hours was sufficient for observation by light microscopy
(Figs. 1-3). Under the specified pH and growth conditions and in the absence of PC, crystals of predicted type
were produced.
Coffin-lid shaped crystals were
observed under pure COM and COM/COD growing
conditions (Figs. la and 3a), whilst the COD crystals
under growth conditions generating either pure COD or
a mixture of COM/COD (Figs. 2a and 3a) were distinct
dipyramidal tetrahedral structures.
When PC (2.22 mM) was included in the gel, COM
crystals were noticeably absent under all three growing

b
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Figure 3. Characteristic morphologies of COM and
COD crystals formed in silicate gel in the presence or
absence of PC, under COM and COD growth conditions. (a). Control. (b) . PC (560 µM) . (c). PC
(2.22 rnM). Bars = 100 µm.

conditions. Even under COM or COM /COD growth
conditions, typical dipyrarnidal COD crystals formed
(Figs. le and 3c) . At a lower PC concentration (560
µM), COM crystal formation (Figs . lb and 3b) was still
impaired and COD crystals showed signs of interpenetrant twinning and mulberry-shaped morphologies.

Foreign body implantation model
Rats receiving the implants remained healthy during
the experimental period , displaying normal weight gain
and food and water consumption. Figure 4 compares an
implant disk prior to insertion (Fig. 4a) with an implant
(now heavily encrusted with crystallite material) removed four weeks later from a control rat (Fig. 4b).
Crystallite deposition was strongly evident in both
treated and control groups. No additional crys tal material (i.e., daughter stones) was found within the bladders
of either the control or PC treated rat groups.
No significant differenc e in the amount of material
accumulating on the implants between the control and
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Figure 4 (at top). Scanning electron micrographs of polym eric epoxy resin implant. (a). Implant before insertion .
Bar = 1 mm. (b). Implant after insertion . A profil e of the encrusted material is shown. Bar = 1 mm .
Figure 5. Surface crystals of stone material growing on implants after 28 days . (a). Surface of encrusted implant
removed from control rat. Bar = 100 µm . (b) . Surface of encrusted bladder implant from rat treated with PC. Bar
= 10 µm .
Table 1. Depo sition of CaOx on bladder implants in control rats and in rats receiving PC .

Time (days)
Rat Group

0
Implanted Disk
Mass (mg)

28
Removed Disk
Mass (mg)

Mass of
Deposit (mg)

Control
(n = 13)

13.91

± 1.77

31.57

± 15. 10

17.66

± 15.24

PC (n= 12)
250 mg/kg/day

13.74

± 1.96

31.18

± 8.87

17.34

± 8.45

Rats were fed a normal chow diet supplemented with 1 % glycolic acid for the 28 day experimental period .
Values are shown as mean ± 1 standard deviation (S.D .).
132
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from COD to COM , although a direct role in preventing
any concurrent COM nucleation cannot be discounted.
Calcium oxalate phase changes have been investigated by a number of researchers who have considered
dissolution and recrystallization rates, as well as solubility and zeta potentials of COM and COD (Tomazic and
Nancollas, 1980; Lepage and Tawashi , 1982; Leusmann
et al., 1984). In the presence of an inhibitor such as
polyphosphate, for example, the data strongly indicate
that dissolution of COD is implicitly controlled by a
surface phenomenon. It is not surprising then that PC,
a molecule possessing several dissociable groups leading
to a strong negative charge and a known strong affinity
for calcium salt crystal surfaces (Richardson et al.,
1990) should affect COD in the manner observed.
Whilst the typical dipyramidal COD shape was still evident with PC present (Figs. 2 and 4), fractured forms of
twinned dipyramid s were also observed in vitro (Fig. 3),
giving further evidence for the notion that the PC was
stabilizing the initial formation of the COD. Kim (1982)
has previously reported such a twinning phenomenon.
Martin et al. (1984) from in vitro studies have similarly
concluded that the inhibitors citrate and pyrophosphate,
increase the prevalence of COD by phase stabilization ,
thus , preventing COD to COM transformation. Another
feature of PC influence was the visual observation that
a smaller sized crysta l of COD was produced. This
probably reflects a slower rate of crys tal generation and
maturation, an obvio us benefit in ultimately passaging
such immatur e crys tallit es through the urinary tract.
The inhibition of COM formation and growth in the
presence of PC was also clearly evident in vitro. At
both concentrations of PC tested, COM formation was
completely eliminated. This finding taken together with
the knowledg e that PC has the ability to disperse COM
crysta ls (Richardson et al ., 1990), makes the compound
a very useful inhibitor.
SEM of the implanted polymer disks revealed a picture of crystal deposition and growth similar to that described by Khan and Hackett (1985b). In their studies ,
they observed COM crysta ls as being present throughout
a CaOx urinary stone from its base to the periphery
(Khan and Hackett, 1993). Iwata et al . (1992) observed
that within a CaOx stone, the COM component is mainly
found throughout the inner layers, whilst the more
prominent COD is present near the surface. In our studies , those rats not receiving PC had poor definition of
crystalline shape in the inner layers next to the disk surface, suggestive of the monohydrate form , with some
COD crystals clearly evident on the surface. More numerous and prominent crystals of COD however , were
evident in those rats treated with PC with some crystals
penetrating deep into the inner layers (Fig. 4). The
qualitative observations from the SEM study were con-

Table 2. The proportion of COD present in stones removed from control and PC treated animals (values are
shown as mean ± 1 S.D. ; n = number of samples).
% COD in Sample

Group
Control (n

= 3)

PC Treated (n = 5)
(250 mg/kg body weight/day)

34.84 ± 3.11
75.65 ± 18.20*

•p = 0.0097 (Student's t-test) .

PC treated groups was evident (Table 1). When the encrusted material was viewed initially under the light
microscope, distinct crystals were more numerous on the
implants from the PC treated rats than from the controls.
Under SEM analysis (Fig. 5), COM crystals were
prominent on the implants from control rats, being typically smooth-surfaced coffin-lid shaped , approximately
100 µ.m in length . Disks removed from rats receiving
PC however, revealed surface crystals of COD (small,
about 10-20 µ.m) of tetrahedral , dipyrimidal habit (Fig.
Sb). No COM crys tals were present on the implant
surface.

Infrared analysis
Spectral profiles obtained with synthetic COM and
COD (not shown here) were identi cal to those previously
well docum ented in the literatur e (e.g., see Martin et
al. , 1984; Oka et al., 1985) . Characteristic spectra l absorption peaks for COM were as follows : a sharp peak
at 780 cm- 1 (maximum absorbance about 65%), a medium-broad peak at 640 cm- 1 (30 %) and a smaller peak at
590 cm- 1 (15 %). The presence of a small, broad peak
at 780 cm- 1 (maximum absorbance 20%) was evidence
for COD.
The fraction of COD present on the recovered implants, assessed as described in the methods , is shown in
Table 2. COD was a minor componen t of the deposits
in the controls whereas, crystalline material from the PC
treated animals was predominantly COD.

Discussion
PC , when present in vitro or in vivo during the generation of COM and/or COD, exerts a marked inhibitory
influence on the formation of the two crystalline types.
Responses to the inhibitor are not however identical.
Crystal habit of the COD produced under our in vivo
trials did not change. Although phase transformation
was not examined per se , it is apparent from the morphological evidence that PC prevented the transformation
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firmed through the quantitative IR analysis, whereby less
COD (35 %) was found on the implants from the untreated rats to that in the PC treated (76 %) . This is new
data with regard to PC action on CaOx , and is in accordance with that found in other CaOx inhibitor studies
(Martin et al., 1984). The amounts of PC actually
transiting the urinary tract are unknown at present due
to the lack of sensitive and specific methods to detect
low concentrations of PC in tissue and fluids.
It might be suggested that in vivo, responses to PC
are a reflection of breakdown of the compound to its
components, citrate and phosphate . This idea however
is not tenable for several reasons. There is no evidence
of strong hydrolytic degradation of PC in vivo and in
previous studies (Williams and Sallis, 1980; Sallis et al.,
1988, 1991), we have demonstrated that equivalent concentrations of citrate or phosphate do not mimic the inhibition observed with PC. Further, and of considerable
interest, Richardson et al. (1990) have reported that citrate can actually potentiate the inhibitory activity of PC .
In summary, the inhibitory properties of PC toward
formation and growth of CaOx crystals have been demonstrated in vitro using a simple gel matrix system and
the observations confirmed in vivo using the more complex environmental conditions present in the rat model.
As a possible useful therapeutic drug then , PC appears
to offer potential. It cannot be stated though that PC or
any other inhibitory compound is capable of totally preventing CaOx crystallites from forming. If the responses seen here are considered in totality, then the
inhibitor does offer the compromise of restraining crysta l
formation and limiting growth size so that the prevailing
crystallites have a chance of being eliminated safely in
the urinary tract. The known greater rate of dissolution
and slower growth of COD compared to COM (Tomazic
and Nancollas, 1980), together with the formation of a
smaller sized crystal in the presence of an inhibitor ,
would assist in their earlier elimination. Clearly, the
rate of urinary excretion would also be an important factor. The correlation of data derived from experimentally
induced stone models to that of clinical human urolithiasis findings is quite considerable on the evidence cited
by Khan et al. (1984) and Khan and Hackett (1985a,
1985b). Therefore, a therapeutic role for PC in postoperative management of patients with a history of stone
recurrence might be a future consideration.
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Discussion With Reviewers
H-G. Tiselius: High concentrations of calcium and
oxalate were apparently added to the system. Which
were the approximate solute concentrations or the calcium oxalate supersaturation at the place of crystal
nucleation?
Authors: Concentrations of individual species were not
assessed at the interface where crysta ls were nucleating
and growing and indeed would be extremely difficult to
measure. In the contex t of the goal of the experiment,
supersaturation of the ionic species in question must
have been achieved because the crystallite morphology
was clearly expressed and reproducible under the respective media condition s.
W. Achilles: In the silica-gel model used in this work,
concentration s of Ca and oxalate are applied at high, unphysiological concentrations (each lM). Can the effect
on crys tal morphology described in this paper also be
observed in gel models which simulate physiological
conditions better than done here?
A.L. Rodgers : Would it be possible to use real urine
(human or rat) in the in vitro experiments instead of
aqueous solutions? The advantages of doing so in terms
of the model 's credibility are obvious.
H.-G. Tiselius : Is it the authors' experience that crystal
nucleation in a gel system of this kind is superior to the
nucleation in a solution in terms of reproducibility?
Authors: Although morphology has not been described,
it is known that PC can inhibit growth of oxalates in gels
under conditions more closely mimicking those occurring physiologically (Achilles et al., 1990) . Further, it
has been demonstrated that crystal growth in gels in the
presence of urine provides a similar profile (Marickar
and Koshy , 1987) . A gel system is not necessarily superior but a useful alternative to other systems because the
morphology of single crystals can be better observed .
In the present study, we were concerned to document the
action of a single inhibitor (PC), uncomplicated by the
presence of extraneous promoters or inhibitors.
A.L. Rodgers: Why did you choose to use an implant,
as opposed to simply examining the crystalluria after
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F. Grases: How do the authors explain that in spite of
detecting low crystalline deposits in the PC treated rats,
no significant difference between the control and PC
treated group in the total amount of accumulated material on the implants was detected?
H.-G. Tiselius: The in vivo experiments clearly show
a lack of difference in the amount of precipitate (Table
1) and the crystals shown in Figures 1 and 3 suggest a
greater volume of the individual crystals with PC than
without. How would you explain the beneficial effects
of PC in calcium oxalate stone formation?
Authors: We are unable to offer a data-based explanation as to why there was no discernible difference in the
mass of deposited material in either the control or
treated groups. It is probable that the concentration
ratios of inhibitor/ionic species for formation and growth
of the crystals would need to be maximal over a 24 hour
period if discernibl e weight differen ces were to become
evident. The pharmacokinetic profile of PC is unknown
at the present time.

inducing the latter with a hyperoxaluric diet? What are
the advantages of the implant model?
Authors: Crystalluria measurements are short-term observations which are not conducive to observing the
longer period required for development of calculi . The
implant model is a more appropriate option as it is possible to quantify and simultaneously observe the morphology of the precipitating crystallites. Foreign body stones
are known to have a similar morphology to human urinary stones (Khan and Hackett, 1985b).
F. Grases: PC was supplied to the rats by intraperitoneal administration, using high doses. What amount
would be necessary to administer orally to produce the
same effects?
Authors: Quantitation of PC at a calcified site is currently beyond our technical capabilities. From in vitro
experiments, we know the inhibitory concentration required to be effective is very low. In the light of probable general tissue and fluid distribution when PC is
given via the ip route, the amount administered therefore
is not considered to be high. Oral bioavailability of PC
is poor [Cooper CM, Sallis JD (1993). Studies on the
gastrointestinal absorption of phosphocitrate, a powerful
controller of hydroxyapatite formatio:i. Int J Pharm 98:
165-172). Consequently, specific site directed prodrugs
of PC to improve transport and general wastage are currently being prepared and tested.
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